Search Results - "Horowski, R"

FG 7142: is this validated tool to study anxiety now forgotten? by Horowski, R.

“…We describe the first human experience with FG 7142, a drug which in a phase I study has caused severe anxiety attacks and which therefore could be a validated…”
Get full text

Japanese medicine and Berlin: a very special and successful relationship by Horowski, R.

“…We describe a unique interaction between the very advanced German medicine and the ambitious Japanese medicine at the end of the 19th century and some of their…”
Get full text

The "Madness" of Friedrich Hölderlin: an iatrogenic intoxication by Horowski, R.

“…The German poet Hölderlin, assumed to have suffered from schizophrenia, in fact has been the victim of a combined calomel and cantharidine intoxication…”
Get full text

Classical dopamine agonists by Horowski, R., Löschmann, P.-A.

“…The pioneering work of Arvid Carlsson has laid the foundation for a number of innovative therapies for severe central nervous system (CNS) diseases. He was…”
Get full text

A history of dopamine agonists. From the physiology and pharmacology of dopamine to therapies for prolactinomas and Parkinson's disease - a subjective view by Horowski, R

“…Issue Title: Intramembrane receptor-receptor interactions and volume transmission…”
Get full text

High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study by Graf, M, Ecker, D, Horowski, R, Kramer, B, Riederer, P, Gerlach, M, Hager, C, Ludolph, A C, Becker, G, Osterhage, J, Jost, W H, Schrank, B, Stein, C, Kostopulos, P, Lubik, S, Wekwerth, K, Dengler, R, Troeger, M, Wuerz, A, Hoge, A, Schrader, C, Schimke, N, Krampfl, K, Petri, S, Zierz, S, Eger, K, Neudecker, S, Traufeller, K, Sievert, M, Neundörfer, B, Hecht, M

“…Increasing evidence has suggested that oxidative stress may be involved in the pathogenesis of amyotrophic lateral sclerosis (ALS). The antioxidant vitamin E…”
Get full text

Lisuride, a dopamine receptor agonist with 5-HT2B receptor antagonist properties: absence of cardiac valvulopathy adverse drug reaction reports supports the concept of a crucial role for 5-HT2B receptor agonism in cardiac valvular fibrosis by Hofmann, C, Penner, U, Dorow, R, Pertz, H H, Jähnichen, S, Horowski, R, Latté, K P, Palla, D, Schurad, B

“…The high incidence of fibrotic cardiac valvulopathies reported in association with the 8beta-ergoline dopamine (DA) agonist, pergolide, and also case reports…”
Get full text

L-DOPA products for continuous dopaminergic stimulation by Horowski, R.

Get full text

P2.171 Transdermal lisuride achieves stable plasma levels in Parkinson's disease (PD) by Vacca, L, Stocchi, F, Latté, K.P, Horowski, R

Get full text

P2.146 Receptor proflle of lisuride at monoaminergic receptors contributes to its high efflcacy in Parkinson's disease and Restless Legs Syndrome by Latté, K.P, Horowski, R, Pertz, H.H

Get full text

Anxiogenic, not psychotogenic, properties of the partial inverse benzodiazepine receptor agonist FG 7142 in man by Horowski, R, Dorrow, R

Get full text

P3.175 Transdermal lisuride is effective in Restless Legs Syndrome (RLS) by Beneŝs, H, Kohnen, R, Horowski, R, Latté, K.P, Palla, D

Get full text

2.251 Possible neuroprotective properties of the dopamine agonist lisuride by Horowski, R, Latté, K.P, Kranda, K, Flieger, M

Get full text

2.250 Continuous dopaminergic stimulation (CDS) with lisuride improves the therapy of Parkinson's disease by Horowski, R, Latté, K.P, Palla, D, Wachtel, H, Löschmann, P.A

Get full text

Striatal plasticity and motor learning—importance of circadian rhythms, sleep stages and dreaming by Horowski, R, Beneš, H, Fuxe, K

“…In this brief comment, we emphasize the importance of circadian rhythms, sleep stages and especially REM sleep for motor and procedural learning which needs to…”
Get full text

Schaltenbrand by Horowski, R

Get full text

Transdermal lisuride delivery in the treatment of Parkinson's disease by Woitalla, D, Müller, T, Benz, S, Horowski, R, Przuntek, H

“…Transdermal delivery of dopamine agonists (DA) is a promising therapeutic concept, which aims to ameliorate frequency and intensity of motor fluctuations in…”
Get more information

CNS research in the pharmaceutical industry. A personal view of how innovation could be promoted by clinical pharmacology by Horowski, R

Get full text

1.IS.4.3 Efficacy and safety of transdermal lisuride (LIS) in advanced Parkinson's disease (PD) by Ebersbach, G, Poewe, W, Bojar, M, Martignoni, E, Rascol, O, Reichmann, H, Sampaio, C, Stocchi, F, Tolosa, E, Runge, I, Horowski, R

Get full text

2.249A Efficacy and safety of transdermal lisuride (LIS) in advanced Parkinson's disease (PD) by Ebersbach, G, Poewe, W, Bojar, M, Martignoni, E, Rascol, O, Reichmann, H, Sampaio, C, Stocchi, F, Tolosa, E, Runge, I, Horowski, R

Get full text